Takanori Yokota
Directeur/Bestuurslid bij Oligonucleotide Therapeutics Society, Inc.
Profiel
Takanori Yokota is the founder of Rena Therapeutics, Inc. which was founded in 2015.
Currently, he is a Director at Oligonucleotide Therapeutics Society, Inc.
Actieve functies van Takanori Yokota
| Bedrijven | Functie | Begin |
|---|---|---|
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Takanori Yokota
| Bedrijven | Functie | Einde |
|---|---|---|
Rena Therapeutics, Inc.
 Rena Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Rena Therapeutics Inc. engages in the provision of third platform technology specifically for creation of new nucleic acid drugs. It offers joint collaborative search business, basic technology licensing and nucleic acid drug development business. The company was founded by Junichi Yano, Takashi Yamamoto and Takanori Yokota on January 15, 2015 and is headquartered in Tokyo, Japan. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Rena Therapeutics, Inc.
Rena Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Rena Therapeutics Inc. engages in the provision of third platform technology specifically for creation of new nucleic acid drugs. It offers joint collaborative search business, basic technology licensing and nucleic acid drug development business. The company was founded by Junichi Yano, Takashi Yamamoto and Takanori Yokota on January 15, 2015 and is headquartered in Tokyo, Japan. | Health Technology |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
